Search

Your search keyword '"Koehm, Michaela"' showing total 126 results

Search Constraints

Start Over You searched for: Author "Koehm, Michaela" Remove constraint Author: "Koehm, Michaela"
126 results on '"Koehm, Michaela"'

Search Results

2. The Potential of Digital Twins in Healthcare: Evaluation of a Clinical Decision Support System for Chronic Inflammatory Bowel Disease

3. Short-term predictor for COVID-19 severity from a longitudinal multi-omics study for practical application in intensive care units

4. Aligning Subjective Ratings in Clinical Decision Making

5. Automated Hand Joint Classification of Psoriatic Arthritis Patients Using Routinely Acquired Near Infrared Fluorescence Optical Imaging

6. Machine Learning Based Approach for Motion Detection and Estimation in Routinely Acquired Low Resolution Near Infrared Fluorescence Optical Imaging

7. An HPA-1a–positive platelet–depleting agent for prevention of fetal and neonatal alloimmune thrombocytopenia: a randomized, single-blind, placebo–controlled, single-center, phase 1/2 proof-of-concept study

8. Cohort Enrichment Strategies for Progressive Interstitial Lung Disease in Systemic Sclerosis From European Scleroderma Trials and Research

9. Methotrexate plus ustekinumab versus ustekinumab monotherapy in patients with active psoriatic arthritis (MUST): a randomised, multicentre, placebo-controlled, phase 3b, non-inferiority trial

10. How do patient-reported outcome measures affect treatment intensification and patient satisfaction in the management of psoriatic arthritis? A cross sectional study of 503 patients.

11. An international multicentre analysis of current prescribing practices and shared decision-making in psoriatic arthritis.

14. How do patient-reported outcome measures affect treatment intensification and patient satisfaction in the management of psoriatic arthritis? A cross sectional study of 503 patients

15. An international multi-centre analysis of current prescribing practices and shared decision-making in psoriatic arthritis

17. Impact of different classes of immune-modulating treatments on B cell-related and T cell-related immune response before and after COVID-19 booster vaccination in patients with immune-mediated diseases and primary immunodeficiency: a cohort study

19. Psoriatic Arthritis

20. ‘Status Quo’ on Different Aspects of Gender Distribution in Rheumatology in Germany—Results from a Nationwide Online Survey among Physicians

25. P178 Current prescribing practices in psoriatic arthritis - comparison between the UK and Europe

26. P179 Shared decision-making in psoriatic arthritis consultations

28. Methotrexate plus ustekinumab versus ustekinumab monotherapy in patients with active psoriatic arthritis (MUST): a randomised, multicentre, placebo-controlled, phase 3b, non-inferiority trial

29. Application of clinical and molecular profiling data to improve patient outcomes in psoriatic arthritis

30. Effectiveness of Different Rituximab Doses Combined with Leflunomide in the Treatment or Retreatment of Rheumatoid Arthritis: Part 2 of a Randomized, Placebo-Controlled, Investigator-Initiated Clinical Trial (AMARA)

31. Fluorescence-optical imaging as a promising easy-to-use imaging biomarker to increase early psoriatic arthritis detection in patients with psoriasis: a cross-sectional cohort study with follow-up

32. An HPA-1a–positive platelet–depleting agent for prevention of fetal and neonatal alloimmune thrombocytopenia: a randomized, single-blind, placebo-controlled, single-center, phase 1/2 proof-of-concept study

33. Management of Enthesitis in Patients With Psoriatic Arthritis: An Updated Literature Review Informing the 2021 GRAPPA Treatment Recommendations

34. Omics and Multi-Omics Analysis for the Early Identification and Improved Outcome of Patients with Psoriatic Arthritis

35. Management of Enthesitis in Patients With Psoriatic Arthritis: An Updated Literature Review Informing the 2021 GRAPPA Treatment Recommendations.

36. Genetic Analysis of MPO Variants in Four Psoriasis Subtypes in Patients from Germany

37. Disease progression in systemic sclerosis-overlap syndrome is significantly different from limited and diffuse cutaneous systemic sclerosis

38. Rare Loss-of-Function Mutation in SERPINA3 in Generalized Pustular Psoriasis

39. Rituximab plus leflunomide in rheumatoid arthritis: a randomized, placebo-controlled, investigator-initiated clinical trial (AMARA study)

41. Incidences and risk factors of organ manifestations in the early course of systemic sclerosis: A longitudinal EUSTAR study

43. Rheumatoid arthritis - treatment: 180. Utility of Body Weight Classified Low-Dose Leflunomide in Japanese Rheumatoid Arthritis

44. Effectiveness of Different Dosages of Retreatment of Rituximab in Combination with Leflunomide: Results from a Multicenter Randomized Placebo Controlled Investigator Initiated Clinical Trial in Active Rheumatoid Arthritis (Amara-Study

50. Rheumatoid arthritis - treatment: 180. Utility of Body Weight Classified Low-Dose Leflunomide in Japanese Rheumatoid Arthritis

Catalog

Books, media, physical & digital resources